It's the transcript of a meeting of an FDA Advisory Panel on Pain Treatment. The FDA pays experts in medical fields to be members of these panels that are tasked with making recomendations on drug approvals and other FDA responsibilities. It was one of these same types of panels that recently recommended overwhelmingly that a "morning after" pill be made OTC. The FDA rejected their advice for political reasons. The FDA does not have to do anything that these panels recommend. The panels represent the science and the medicine. Hopefully, the FDA considers those factors, but for some issues politics and money will prevail.